Patient experience of bladder cancer: A data linkage study

IF 1.6 Q3 UROLOGY & NEPHROLOGY BJUI compass Pub Date : 2024-01-31 DOI:10.1002/bco2.325
Snehadhar Shah, Jonathan Ince, Roger Kockelbergh
{"title":"Patient experience of bladder cancer: A data linkage study","authors":"Snehadhar Shah,&nbsp;Jonathan Ince,&nbsp;Roger Kockelbergh","doi":"10.1002/bco2.325","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Bladder cancer is one of the most common cancers worldwide and can be managed with a range of approaches, including conservative, medical and surgical therapies. Treatment may be associated with considerable morbidity, but despite this, little data exist to reflect patients' subsequent experience. This study aims to evaluate patients' experiences of bladder cancer care by linking data from a national cancer experience survey with data routinely collected from National Health Service (NHS) sources. This study considers patient perspectives and makes recommendations to improve the patient experience of bladder cancer care.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Anonymised data from the National Cancer Patient Experience Survey (NCPES) for patients who had received care for bladder cancer were collated and linked with demographic and treatment data. Questions from the NCPES were then categorised into different themes based on their content. This study focused on themes relating to lifestyle, activities of daily living (ADL), symptoms, psychological impact and body perception. Statistical analyses were used to investigate the relationship between patient reported experience, demographics and type of care received.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>NCPES data from 673 patients (487 male, 29 undisclosed) with at least T1 bladder cancer were analysed. Statistically significant differences were identified across the five investigated patient experience themes. No significant difference was seen in patient reported experience between bladder cancer drug treatments (such as intravesical BCG vs. intravesical chemotherapy vs. systemic chemotherapy) and radiotherapy types (curative vs. palliative). Patients treated with cystectomy had significantly worse experiences relating to body image and ADL but not when compared with patients treated with radical radiotherapy. Patients with long-term health conditions reported worse experiences for all five themes compared with those without.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The literature surrounding the experience of patients with bladder cancer is limited. This data linkage study demonstrates the impact of bladder cancer care on five patient experience themes, including the effect of different treatment types and the presence of long-term health conditions. While limited by sample size and data comprehensiveness, this study aims to inform clinicians and service providers of factors affecting patient experience of bladder cancer care, to stimulate service review and development.</p>\n </section>\n </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"5 3","pages":"382-388"},"PeriodicalIF":1.6000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.325","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJUI compass","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bco2.325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Bladder cancer is one of the most common cancers worldwide and can be managed with a range of approaches, including conservative, medical and surgical therapies. Treatment may be associated with considerable morbidity, but despite this, little data exist to reflect patients' subsequent experience. This study aims to evaluate patients' experiences of bladder cancer care by linking data from a national cancer experience survey with data routinely collected from National Health Service (NHS) sources. This study considers patient perspectives and makes recommendations to improve the patient experience of bladder cancer care.

Methods

Anonymised data from the National Cancer Patient Experience Survey (NCPES) for patients who had received care for bladder cancer were collated and linked with demographic and treatment data. Questions from the NCPES were then categorised into different themes based on their content. This study focused on themes relating to lifestyle, activities of daily living (ADL), symptoms, psychological impact and body perception. Statistical analyses were used to investigate the relationship between patient reported experience, demographics and type of care received.

Results

NCPES data from 673 patients (487 male, 29 undisclosed) with at least T1 bladder cancer were analysed. Statistically significant differences were identified across the five investigated patient experience themes. No significant difference was seen in patient reported experience between bladder cancer drug treatments (such as intravesical BCG vs. intravesical chemotherapy vs. systemic chemotherapy) and radiotherapy types (curative vs. palliative). Patients treated with cystectomy had significantly worse experiences relating to body image and ADL but not when compared with patients treated with radical radiotherapy. Patients with long-term health conditions reported worse experiences for all five themes compared with those without.

Conclusion

The literature surrounding the experience of patients with bladder cancer is limited. This data linkage study demonstrates the impact of bladder cancer care on five patient experience themes, including the effect of different treatment types and the presence of long-term health conditions. While limited by sample size and data comprehensiveness, this study aims to inform clinicians and service providers of factors affecting patient experience of bladder cancer care, to stimulate service review and development.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
膀胱癌患者的经历:数据关联研究
简介:膀胱癌是全球最常见的癌症之一,可通过一系列方法进行治疗,包括保守治疗、药物治疗和手术治疗。治疗可能会导致相当高的发病率,但尽管如此,反映患者后续经历的数据却很少。本研究旨在通过将全国癌症经验调查的数据与国民健康服务系统(NHS)定期收集的数据联系起来,评估患者的膀胱癌治疗经验。本研究考虑了患者的观点,并提出了改善患者膀胱癌治疗体验的建议。 方法 对全国癌症患者体验调查(NCPES)中有关接受过膀胱癌治疗的患者的匿名数据进行整理,并将其与人口统计学和治疗数据联系起来。然后将 NCPES 中的问题根据其内容分为不同的主题。本研究侧重于与生活方式、日常生活活动 (ADL)、症状、心理影响和身体感知有关的主题。统计分析用于研究患者报告的经历、人口统计学特征和所接受的护理类型之间的关系。 结果 对 673 名至少患有一级膀胱癌的患者(487 名男性,29 名未披露)的 NCPES 数据进行了分析。在五个调查的患者体验主题中发现了统计学上的重大差异。在膀胱癌药物治疗(如膀胱内卡介苗与膀胱内化疗与全身化疗)和放疗类型(根治性与姑息性)之间,患者报告的体验无明显差异。接受膀胱切除术治疗的患者在身体形象和日常活动能力方面的体验明显较差,但与接受根治性放疗的患者相比,情况并非如此。与无长期健康状况的患者相比,有长期健康状况的患者在所有五个主题方面的体验都较差。 结论 有关膀胱癌患者经历的文献十分有限。这项数据关联研究证明了膀胱癌治疗对五个患者体验主题的影响,包括不同治疗类型的影响和是否存在长期健康状况。虽然受到样本量和数据全面性的限制,但本研究旨在让临床医生和服务提供者了解影响膀胱癌患者护理体验的因素,从而促进服务的审查和发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Issue Information Issue Information Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive bladder cancer outcomes: 12-Month follow-up data from the international, prospective COVIDSurg Cancer study Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1